Bioxcel Therapeutics shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $52k | 19k | 2.82 |
| 2023-12-31 | $56k | 19k | 2.95 |
| 2023-09-30 | $42k | 17k | 2.53 |
| 2023-06-30 | $124k | 19k | 6.66 |
| 2023-03-31 | $262k | 14k | 18.66 |
| 2022-12-31 | $342k | 16k | 21.48 |
| 2022-09-30 | $142k | 12k | 11.84 |
| 2022-06-30 | $163k | 12k | 13.24 |
| 2022-03-31 | $229k | 11k | 20.94 |
| 2021-09-30 | $247k | 8.1k | 30.39 |
| 2021-06-30 | $211k | 7.3k | 29.09 |
| 2020-09-30 | $700k | 16k | 43.34 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates